Sign Up Today and Learn More About Cureatr Stock
Invest in or calculate the value of your shares in Cureatr or other pre-IPO companies through EquityZen's platform.
![Cureatr](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/cureatr_logo-8168e2d8556515f7.png)
Cureatr Stock
Cureatr is a medication management and optimization company that sells tech and tech-enabled services to at-risk health care enterprises.
About Cureatr Stock
Founded
2011
Headquarters
New York, NY, US
Industries
Software, Health Care, Information Technology
Cureatr Press Mentions
Stay in the know about the latest news on Cureatr
Cureatr Welcomes Industry Veteran Craig Petty as SVP of Client Success
prnewswire • Aug 13, 2024
AssureCare Acquires Cureatr and SinfoniaRx Technology
globenewswire • Jul 05, 2024
Cureatr Welcomes Industry Veteran Craig Petty as SVP of Client Success
morningstar • Oct 05, 2023
CUREator+ delivers $50m funding boost for BioMedTech startups
dynamicbusiness • Aug 22, 2023
Medication Management Services Leader Cureatr Acquires SinfonĂaRx
prnewswire • Mar 04, 2023
Cureatr Management
Leadership team at Cureatr
Chief Revenue Officer
Aerste Howells
Principal Software Engineer
Andrew Wason
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Cureatr current valuation
- Cureatr stock price
- Available deals in Cureatr and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cureatr stock?
Accredited investors can buy pre-IPO stock in companies like Cureatr through EquityZen funds. These investments are made available by existing Cureatr shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cureatr stock?
Shareholders can sell their Cureatr stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."